Follow the Money to Medical Devices & Diagnostics
Spotlight on SEBACIA, Inc.
Follow the Money to Medical Device & Diagnostic Opportunities highlights a newly funded medical device or diagnostic company. This includes important insights into the featured company’s product pipeline, manufacturing and business relationships, and likely sourcing opportunities.
SEBACIA, Inc. is a US private company that develops light-based therapies for the treatment of dermatological conditions. It raised $36 million in the completion of a mixed financing round as reported in the PharmSource Lead Sheet on July 27, 2017.
- SEBACIA was founded in 2010
- Corporate Headquarters: Duluth, GA
- SEBACIA plans to use the proceeds to support the US clinical trials and EU marketing efforts for its product pipeline for the treatment of acne.
Device: Sebacia Acne Treatment System™
Development Phase: Pivotal studies
Medical Specialty: Dermatology/Wound Care
Purpose: Device – Therapeutic/Interventional
Type: System/System accessory; Laser/Ablation/Electrosurgical
Description: A dermatology product that combines proprietary Sebashell microparticles with focused heating from a hair removal laser.
- June 2015: $22 million in a completed venture capital investment
- June 2015: $8 million in a completed venture capital investment
Medical Device & Diagnostics Pipeline1
|Product Candidate||Indication||Medical Specialty||Purpose||Type||Status|
|Sebacia Acne Treatment System||Moderate-to-severe acne||Dermatology/Wound Care||Device – Therapeutic/
1Source: PharmSource Lead Sheet
|SEBACIA, Inc.||Key Officers|
|2905 Premiere Parkway, Suite 150||Anthony Lando, CEO|
|Duluth, GA, 30094 USA||Gretchen Richard, VP, Clinical & Regulatory Affairs|
|Phone: +1-888-935-4411||Richard Blomgren, Director, Quality|
|Web: http://www.sebacia.com/||Cory Anderson, VP, Clinical Marketing|
Follow the Money to Medical Device & Diagnostic Opportunities – Spotlight on Titan Medical, Inc.
Follow the Money to Medical Device & Diagnostic Opportunities – Spotlight on CartiHeal Ltd.
Follow the Money to Medical Device & Diagnostic Opportunities – Spotlight on Aspect Imaging, Inc.